[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS59231019A - Paint - Google Patents

Paint

Info

Publication number
JPS59231019A
JPS59231019A JP10479483A JP10479483A JPS59231019A JP S59231019 A JPS59231019 A JP S59231019A JP 10479483 A JP10479483 A JP 10479483A JP 10479483 A JP10479483 A JP 10479483A JP S59231019 A JPS59231019 A JP S59231019A
Authority
JP
Japan
Prior art keywords
camphor
methyl salicylate
paint
chlorophyll
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10479483A
Other languages
Japanese (ja)
Inventor
Mitsuru Uenami
植波 満
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP10479483A priority Critical patent/JPS59231019A/en
Publication of JPS59231019A publication Critical patent/JPS59231019A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE:A paint effective for the stiffness of the shoulders, lumbagos, and arthralgia, obtained by blending methyl salicylate and d-camphor as main agents with a peppermient oil as an odorizing agent and chlorophyll as a coloring matter, dissoving the blend in ethanol. CONSTITUTION:Methyl salicylate and d-camphor as main agents are blended with small amounts of peppermint oil as an odorizing agent and chlorophyll as a coloring matter, and these components are dissolved in a large amount of ethanol to give a paint. It shows excellent effects on the stiffness of the shoulders, lumbagos, and arthralgia by applying it to the affect part several times a day. This paint is yellowish green liquid, has aroma, and can provide users with cooling and refreshing feeling of the applied part.

Description

【発明の詳細な説明】 本発明は肩こり、腰痛、筋肉痛に有効な塗布薬に関する
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a liniment effective for treating stiff shoulders, lower back pain, and muscle pain.

従来、肩こり、腰痛、筋肉痛には有効な薬剤が少なく、
その出現が待望されていた。
Until now, there were few effective drugs for stiff shoulders, lower back pain, and muscle pain.
Its appearance was long awaited.

本発明の目的は、すぐれた外観及び使用感を有する塗布
薬を提供せんとするにある。
An object of the present invention is to provide a liniment having an excellent appearance and feeling of use.

本発明は、サリチル酸メチルとd−カンフルを主剤とし
、着香料としてはっか油を、着色料として葉緑素を小量
添加し、これら成分を多量のエタノールに溶解して成る
ことを特徴とする塗布薬である。
The present invention is a liniment characterized by containing methyl salicylate and d-camphor as main ingredients, adding mint oil as a flavoring agent and a small amount of chlorophyll as a coloring agent, and dissolving these ingredients in a large amount of ethanol. be.

本発明の塗布薬の配合成分中サリチル酸メチルは強い香
気を有する無色の液体であり、融点−8,3℃、沸点2
24℃で水に若干可溶であり、歯みがき用香料、菓子、
チューインガム等に用いられている。d−カンフルはい
わゆる樟脳であり、無色透明な固体で、板状晶であり、
特異なにおいと初め焼くような味があり、終りに清涼な
味があり、呼吸、血管、心臓興奮等の作用を有すること
が知られている。はっか油は芳香成分が多く、駆風剤。
Methyl salicylate, which is a component of the liniment of the present invention, is a colorless liquid with a strong aroma, and has a melting point of -8.3°C and a boiling point of 2.
Slightly soluble in water at 24°C, it can be used as flavoring for toothpaste, confectionery, etc.
Used in chewing gum, etc. d-camphor is so-called camphor, and is a colorless and transparent solid with plate-like crystals.
It has a unique odor, a burning taste at the beginning, and a refreshing taste at the end, and is known to have effects on breathing, blood vessels, and heart stimulation. Peppermint oil has a lot of aromatic components and is a carminative.

芳香調味料、香粧品、チューインガム等に用いられてい
る。又葉緑素、すなわちクロロフィルはマグネシウム原
子を有する高分子量のビロール化合物の一つであるが、
食品等に緑色を与えるために用いられている。本発明の
塗布薬はこれらの配合成分を適量含有するものであり、
以下に実施例につき説明する。
It is used in aromatic seasonings, cosmetics, chewing gum, etc. Chlorophyll, or chlorophyll, is a high molecular weight virol compound containing magnesium atoms.
It is used to give green color to foods. The liniment of the present invention contains appropriate amounts of these ingredients,
Examples will be explained below.

実施例 サリチル酸メチル    600 g d−カンフル       500g はっか油        15m7! 葉緑素−0,5g をエタノールに混合熔解し、全量を10βとした。Example Methyl salicylate 600g d-camphor 500g Mint oil 15m7! Chlorophyll - 0,5g was mixed and dissolved in ethanol to make the total amount 10β.

本発明の塗布薬は、多数の人に対して1回数回患部に塗
布して使用し、肩こり、腰痛、筋肉痛に著効を有するこ
とを確かめた。
The liniment of the present invention was used by a large number of people by applying it to the affected area once, and it was confirmed that it was effective for treating stiff shoulders, lower back pain, and muscle pain.

本発明塗布薬の規格および試験方法は次の通りである。The specifications and testing methods for the liniment of the present invention are as follows.

規格および試験方法 〔含量規格〕 水晶は定量するとき、サリチル酸メチル(CsH9Or
>  5.4〜6.6 v/v%、d−カンフル(C1
011160)  4.5〜5.5 v/v%を含む。
Standards and test methods [Content standards] When quantifying crystals, methyl salicylate (CsH9Or
>5.4-6.6 v/v%, d-camphor (C1
011160) Contains 4.5-5.5 v/v%.

〔性  状〕[Sexual condition]

水晶は淡黄緑色の澄明な液で、特異でそう快な芳香があ
る。
Quartz is a clear, pale yellow-green liquid with a unique and pleasant aroma.

水晶の比重は、約0.816である。The specific gravity of the crystal is approximately 0.816.

〔確認試験〕 (11水晶2  ml!に塩化第二鉄試液1滴を加える
とき、液は赤紫色を呈する。
[Confirmation test] (11 When 1 drop of ferric chloride test solution is added to 2 ml of quartz crystal, the liquid exhibits a reddish-purple color.

(サリチル酸メチル) (2)  定量法で得た第3のピークの保持時間と、日
周サリチル酸メチルについて同様に操作して得たピーク
の保持時間とは一致する。
(Methyl salicylate) (2) The retention time of the third peak obtained by the quantitative method coincides with the retention time of the peak obtained by the same operation for diurnal methyl salicylate.

(サリチル酸メチル) (3)定量法で得た第2のピークの保持時間と、日周d
−カンフルについて同様に操作して得たピークの保持時
間とは一致する。  (d−カンフル)(4)水晶の水
溶液(1→5)は、波長402〜412nmおよび62
5〜635r+mに吸収の極大を示す。
(Methyl salicylate) (3) Retention time of the second peak obtained by quantitative method and diurnal period d
-The retention time of the peak obtained in the same manner for camphor agrees with the retention time. (d-camphor) (4) The aqueous solution of crystal (1 → 5) has a wavelength of 402 to 412 nm and a wavelength of 62 nm.
Maximum absorption is shown between 5 and 635 r+m.

(銅クロロフイリンナトリウム) 〔定量法〕 水晶9.0mβを正確に量り、これに、正確に調整した
50v/v%アセト酢酸エチルエタノール溶液1.0 
rnlρを正確に加え、十分に熔解する。その液5μβ
を正確にとり、つぎの条件を用い、ガスクロマトグラフ
法によって試験を行なう。
(Copper chlorophyllin sodium) [Quantitative method] Accurately weigh 9.0 mβ of quartz, add 1.0 ml of precisely adjusted 50 v/v% ethyl acetoacetate ethanol solution
Add rnlρ accurately and melt thoroughly. The liquid 5μβ
Accurately measure and conduct the test using the gas chromatography method using the following conditions.

サリチル酸メチルおよびd−カンフルのピーク面積(A
+ 、A2) 、アセト酢酸エチルのピーク面積(B)
およびピーク面積比(A+ / B 、 A2 /B)
を、それぞれ半値幅法によって求め、あらかじめ作成し
た検量線により、サリチル酸メチルよびd−カンフルの
量を求める。
Peak areas of methyl salicylate and d-camphor (A
+, A2), peak area of ethyl acetoacetate (B)
and peak area ratio (A+/B, A2/B)
are determined by the half-width method, respectively, and the amounts of methyl salicylate and d-camphor are determined using a calibration curve prepared in advance.

検量線の作成 サリチル酸メチルおよびd−カンフルを正確に2゜4.
6,8,10 v/v%含むエタノール溶液9.0LI
lβを正確に量り、50v/v%アセト酢酸エチル(内
部標準物質)エタノール溶液1.0 m12を正確に加
えて調製し、試料溶液とする。
Preparation of a calibration curve Methyl salicylate and d-camphor were mixed at exactly 2°4.
Ethanol solution containing 6,8,10 v/v% 9.0LI
Accurately measure lβ and add exactly 1.0 ml of 50v/v% ethyl acetoacetate (internal standard) ethanol solution to prepare a sample solution.

試料溶液5μβずつをガスクロマトグラフに注入し、得
られたガスクロマトグラフからピーク面積を半値幅法で
それぞれ求め、試料と内部標準物質とのピーク面積比を
縦軸に、サリチル酸メチルおよびd−カンフル濃度を横
軸にとり、検量線を作成する。
Inject 5μβ of each sample solution into a gas chromatograph, calculate the peak area from the obtained gas chromatograph using the half-width method, and calculate the concentrations of methyl salicylate and d-camphor using the peak area ratio of the sample and internal standard as the vertical axis. Take the horizontal axis and create a calibration curve.

操作条件 検出器:熱伝導度型検出器 分離管:内径3關、長さ1.5mのカラムに3%0V−
17クロ% 7 /l/ブW 60〜80 neshを
充填する。
Operating conditions Detector: Thermal conductivity type detector Separation tube: 3% 0V in a column with an inner diameter of 3 and a length of 1.5 m
Fill with 17% 7/l/bu W 60-80 nesh.

分離管温度=115℃ キャリヤーガスおよび流速:ヘリウム(He)圧力1k
g/c++を 本発明塗布薬の使用上の注意は下記の如くである。
Separation tube temperature = 115°C Carrier gas and flow rate: Helium (He) pressure 1k
The precautions for using the g/c++ liniment of the present invention are as follows.

〔使用上の注意〕[Precautions for use]

1、 次の部位には使用しないこと。 1. Do not use on the following areas.

(1)目の周囲、粘膜等。(1) Around the eyes, mucous membranes, etc.

(2)湿疹、かぶれ、傷口。(2) Eczema, rash, and wounds.

2、次の人は使用前に医師または薬剤師に相談すること
2. The following people should consult a doctor or pharmacist before use.

(1)今までに薬や化粧品等によるアレルギー症状(例
えば発疹1発赤、かゆみ、かぶれ等)を起こしたことが
ある人。
(1) People who have ever had allergic symptoms (e.g. rash, redness, itching, rash, etc.) due to medicines, cosmetics, etc.

(2)湿潤やただれのひどい人。(2) People with severe dampness or sores.

(3)医師の治療を受けている人。(3) Persons receiving treatment from a doctor.

3、使用に際して、次のことを注意する。3. Pay attention to the following when using.

(1)  定められた用法を守ること。(1) Observe the prescribed usage.

(2)小児に使用させる場合には、保護者の指導監督の
もとに使用させること。
(2) When allowing children to use this product, it must be used under the guidance and supervision of their guardians.

(3)  目に入らないよう注意すること。万−目に入
った場合には、すぐに水またはぬるま湯で洗うこと。な
お、症状が重い場合には、眼科医の診療を受けること。
(3) Be careful not to get it in your eyes. - If it gets into your eyes, wash immediately with water or lukewarm water. If the symptoms are severe, please consult an ophthalmologist.

4、使用中または使用後は、次のことに注意すること。4. Pay attention to the following during or after use.

(11本則の使用により、発疹7発赤、かゆみ等の症状
があられれた場合には、使用を中止し、医師または薬剤
師に相談すること。
(If you experience symptoms such as rash, redness, or itching after using the 11 rules, stop using the product and consult your doctor or pharmacist.

(2)数日間使用しても症状の改善がみられない場合に
は、使用を中止し、医師または薬剤師に相談すること。
(2) If your symptoms do not improve even after using the product for several days, stop using it and consult your doctor or pharmacist.

5、保管および取扱上の注意 (1)小児の手のとどかない所に保管すること。5. Precautions for storage and handling (1) Store out of reach of children.

(2)  直射日光をさけ、なるべく涼しいところに密
栓して保管すること。
(2) Avoid direct sunlight and store in a tightly closed place as cool as possible.

(3)誤用をさけ、品質を保持するため、他の容器に入
れかえないこと。
(3) To avoid misuse and maintain quality, do not transfer to another container.

(4)  火気に近づけないこと。(4) Keep away from fire.

本発明によれば、下記の効果がある。According to the present invention, there are the following effects.

■ 美しい黄緑色の液体で芳香があり、塗布部の冷涼感
と爽快感を使用者に与える。
■ It is a beautiful yellow-green liquid with an aroma that gives the user a cool and refreshing feeling when applied.

■ 肩こり、腰痛、筋肉痛に著効がある。■ It is highly effective for stiff shoulders, lower back pain, and muscle pain.

特許出願人   植 波   満 代理人 手掘 益(ばか2名)Patent applicant Mitsuru Ueha Agent Tebori Masu (2 idiots)

Claims (1)

【特許請求の範囲】[Claims] 1、 サリチル酸メチルとd−カンフルを主剤とし、着
香料としてはっか油を、着色料として葉緑素を小量添加
し、これら成分を多量のエタノールに溶解して成ること
を特徴とする塗布薬。
1. A liniment characterized by containing methyl salicylate and d-camphor as main ingredients, adding mint oil as a flavoring agent and a small amount of chlorophyll as a coloring agent, and dissolving these ingredients in a large amount of ethanol.
JP10479483A 1983-06-10 1983-06-10 Paint Pending JPS59231019A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10479483A JPS59231019A (en) 1983-06-10 1983-06-10 Paint

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10479483A JPS59231019A (en) 1983-06-10 1983-06-10 Paint

Publications (1)

Publication Number Publication Date
JPS59231019A true JPS59231019A (en) 1984-12-25

Family

ID=14390350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10479483A Pending JPS59231019A (en) 1983-06-10 1983-06-10 Paint

Country Status (1)

Country Link
JP (1) JPS59231019A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999026589A2 (en) * 1997-11-26 1999-06-03 Andrea Carnevali Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446819A (en) * 1977-09-21 1979-04-13 Lion Dentifrice Co Ltd Surgical antiiinflammatory and anodyne agent
JPS5777626A (en) * 1980-06-25 1982-05-15 Procter & Gamble Palatable composition containing oil or oily substance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446819A (en) * 1977-09-21 1979-04-13 Lion Dentifrice Co Ltd Surgical antiiinflammatory and anodyne agent
JPS5777626A (en) * 1980-06-25 1982-05-15 Procter & Gamble Palatable composition containing oil or oily substance

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999026589A2 (en) * 1997-11-26 1999-06-03 Andrea Carnevali Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
WO1999026589A3 (en) * 1997-11-26 1999-08-12 Andrea Carnevali Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation

Similar Documents

Publication Publication Date Title
B Zawilska “Legal Highs”-New Players in the Old Drama
DE3435040A1 (en) PHARMACEUTICAL COMPOSITION SUITABLE FOR TREATING HANG OVER SYMPTOMS
JP2016145179A (en) Minoxidil-containing liquid medicine for external use, and manufacturing method of liquid medicine for external use
Bouskela et al. Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch
JP6052686B2 (en) Liquid for external use
CN106389205A (en) Mouthwash with sodium copper chlorophyllin
JPH0465051B2 (en)
JPS59231019A (en) Paint
CN111888308B (en) Toothpaste for preventing oral ulcer and accelerating oral mucosa repair and process
CN104997790A (en) Compound skin cream for treating leucoderma
JP3839438B2 (en) Atopic disease prevention / treatment agent
JP4941977B2 (en) Oral jelly-like pharmaceutical composition of benzisoxazole derivative
JPH06287135A (en) External agent composition for skin
Garg et al. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation
KR20050026527A (en) Chinese herb medicine composition in the form of jelly
JP5859166B1 (en) Potassium iodide jelly-like pharmaceutical composition
JPH04128234A (en) Hypnosis promoter
JPH0137370B2 (en)
WO2017051585A1 (en) Inhaling fragrance, perfume, and food flavoring
RU2771084C2 (en) Pharmaceutical composition for buccal/gingian introduction of paracetamol
JP2009280573A (en) Body odor inhibitor for internal use
JPH038744B2 (en)
Foltin et al. Behavioral effects of ethanol and marijuana, alone and in combination with cocaine in humans
Slavin Recreational use of amyl nitrite
Peña et al. Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep